Ganga Pharmaceuticals

Sector: Healthcare

Followers

8
8
6
6
.
1
1
1
1
0.00 (0.00%)

As on 20 Nov, 2025 | 16:00

Open Trading A/c
Day Range
11.68
11.68
LH
52 Week Range
9.25
19.20
LH
Volume
* i
Bid / Ask
0.00
0.00 / 0.00

Ganga Pharmaceuticals Announcements

Statement of Deviation or Variation for the half year ended September 30, 2025

07 Nov, 2025 | 07:27pm • Source: BSE

Un-audited financial results of the Company for the half year ended on September 30, 2025

07 Nov, 2025 | 02:56pm • Source: BSE

Outcome of the Board Meeting pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 held on Friday, November 07,...

07 Nov, 2025 | 02:49pm • Source: BSE

Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 ,inter alia, to consider and...

03 Nov, 2025 | 12:00pm • Source: BSE

Certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025

09 Oct, 2025 | 01:37pm • Source: BSE

Intimation regarding closure of trading window

26 Sep, 2025 | 07:58pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna

22 Sep, 2025 | 01:08pm • Source: BSE

The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna

22 Sep, 2025 | 01:08pm • Source: BSE

Proceedings and Voting Results along with the Scrutinizer Report of 36th Annual General Meeting of Ganga Pharmaceuticals Limited held on Saturday, September 20, 2025

20 Sep, 2025 | 07:02pm • Source: BSE

Proceeding and Voting Results of the 36th Annual General Meeting (AGM) of Ganga Pharmaceuticals Limited (the Company) held on Saturday, September 20, 2025

20 Sep, 2025 | 06:53pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Plutus Capital Management LLP

19 Sep, 2025 | 05:42pm • Source: BSE

Newspaper Publication of Notice of 36th AGM

28 Aug, 2025 | 06:25pm • Source: BSE

Please find enclosed herewith copy of letter send to shareholders (whose email addresses are not registered with Company/RTA/ Depository Participants.

26 Aug, 2025 | 07:37pm • Source: BSE

Please find enclosed the Annual Report for the Financial Year 2024-25

26 Aug, 2025 | 07:32pm • Source: BSE

This is to inform you that 36th Annual General Meeting of the Company for the Financial Year 2024-25 is scheduled to be held on Saturday,...

26 Aug, 2025 | 07:17pm • Source: BSE

Appointment of Statutory Auditor

20 Aug, 2025 | 08:11pm • Source: BSE

Corporate Action - Fixes Book closure for (AGM)

20 Aug, 2025 | 07:34pm • Source: BSE

Intimation for 36th Annual General Meeting scheduled to be held on Saturday, September 20, 2025

20 Aug, 2025 | 07:31pm • Source: BSE

Outcome of the Board Meeting held on Wednesday, August 20, 2025

20 Aug, 2025 | 07:26pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajlal Tanna

05 Aug, 2025 | 03:35pm • Source: BSE